Fig. 2From: Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021Number of overdose AEs by year in people with a DAA listed as the suspect product. AEs, adverse events; DAA, direct-acting antiviralBack to article page